Eduardo Escobedo C., MBA

• Set mission and oversee execution. • Assess/Research current market to create effective focused strategies. • Develop and implement the business short, medium and long-term priorities align with the strategic objectives. • Represent the company in potential negotiations with customers, suppliers and other key contacts. • Manage business operations, finances and strategic alliances.

• Responsible for CathLab strategy design / execution, deliver KPI's. commercial, financial and clinical objetives at Government & Private Healthcare Institutions. • Accountable for multi-brand high specialty therapies: Structural Hearth, Coronary, Neurovascular, Aortic, Cardiac Rhythm Management, Cryoablation, Peripheral, Endovenous, Electrophysiology and Cardiac Surgery. • Exceeded commercial objectives each fiscal year. Achieved consistent annual commercial objectives exceeding +300% growth, increasing billing from USD $3.5 to $10.5 million. • Identify and develop new and existing markets and clients base to help with business expansion. Influence opinions of key stakeholders to maximize brand performance. • Lead, coach, and ensure accountability among a multibrand Sales Representative, Clincial Specialist and Therapy Specialist team. Ensure regular updates on Sales Team skills in terms of medical, technical, and special in-field knowledge areas. Accountable for human resources development objectives.

• Developed, executed, and achieved commercial objectives in the northern region, leading Bard-Bd portfolio transition. Therapies: Surgery, Oncology, Hernia, Urology, Biopsy, Peripheral Vascular, and Infection Prevention. • Exceeded 2019 commercial objectives, attained and surpassed business plan coverage, exceeding budget by MXP $120 million. • Designed and executed strategy for business development and sales increase by actively growing existing accounts and seeking new customers across diverse channels. • Played an essential role in achieving the company's Mexico business objectives, directly (and indirectly) driving sales growth and improving our overall profitability

• Exceeded objectives by achieving 120% contract execution • Represented legally the company and designed / executed commercial plans. • Developed strong vertical and horizontal commecial relationships with key players in government and private institutions. • Specialized in deliver integrated services at interventional cardiology, surgery, cardiac rhythm management, electrophysiology), oncology, ophthalmology, endoscopy, urology, clinical laboratory, blood bank, and orthopedics / osteosynthesis.

• Identify potential new customers and grow revenue in new accounts. • Sales increased from USD $1.2 million in 2012 to USD $7.1 million by 2016. Secured best contracts for Boston Scientific Mexico at IMSS, totaling USD $2.6 million in 2016. • Transformed the region in critical accounts with strong commercial strategy and presence. Mapped needs, developed business plan, and distributors action plan execution, resulting in annual commercial objectives exceded each fiscal year, escalating billing from USD $1.2 to $7.1 million

• Achieved objectives for the North-Gulf Region business plan, managing inclusion and demand growth in government and private health institutions. Built effective teams. • Secured an 80% increase in demand for Neocate. Successfully included, purchased, and generated demand for the 5398 key at IMSS in Northern Mexico. • Monitor and consolidate the outcomes of regional engagement and account plans to feed the brand planning process and to anticipate market needs and/or changes.

• Deliver sales performance and relevant Brands’ Key Performance Indicators (KPIs) to meet or exceed district sales plan within expense budgets. • Ensure district priorities, activities and engagement plans are aligned with brand strategy and national strategic priorities in order to optimize strategic momentum and drive brand success. • Optimize resource utilization by leading, developing, and coaching multi-brand Sales Team. Management Systems and KPIs to continuously improve district sales performance.